Chemistry:Obefazimod
From HandWiki
Obefazimod is an investigational new drug that is being evaluated for the treatment of ulcerative colitis.[1] It is miR-124 micro RNA upregulator.[2] Obefazimod was developed by the French biotech company Abivax SA, whose shares rose by more than 500% when the phase 3 data showed promising results.
References
- ↑ "Obefazimod - Abivax". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800039967.
- ↑ "MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis". Pharmacological Research 194. August 2023. doi:10.1016/j.phrs.2023.106870. PMID 37499702.
 |  |
